Eumnet- European Network for Myelofibrosis:
Consensus on definition of disease improvement and biological impact of new therapies.

Eumnet's objectives are:
To establish a sustainable European network across borders aimed at delivering the benefits of an evidence-based knowledge to the scientific community.
To identify and promulgate a core set of outcome variables for Myelofibrosis with Myeloid Metaplasia through a set of international surveys and a combination of statistical and consensus (Delphi Technique) formation techniques.
To study the biological impact of a new class of drugs, the tyrosine kinase inhibitors, in the outcome of the disease.